Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
SGYPW was delisted on the 6th of December, 2016.
3 hedge funds and large institutions have $210K invested in Synergy Pharmaceuticals, Inc. - Warrants in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
866% more call options, than puts
Call options by funds: $2.81M | Put options by funds: $291K
0% more funds holding
Funds holding: 3 → 3 (0)
88% less capital invested
Capital invested by funds: $1.69M → $210K (-$1.48M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$5.65K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$288 |
SGYPW Hedge Fund Activity: Q1 2016 in Review
3 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q1 2016, worth a combined $210K — down 88% from $1.69M a quarter earlier.
Fund positioning in SGYPW was balanced in Q1 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Sabby Management, cutting an estimated $5.65K.
- 3 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $210K of Synergy Pharmaceuticals, Inc. - Warrants stock for Q1 2016, down 88% quarter-over-quarter.
- 0 funds opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q1 2016 and 0 closed out.
- The largest Synergy Pharmaceuticals, Inc. - Warrants seller in Q1 2016 was Sabby Management, an estimated $5.65K sold.
Based on aggregated 13F filings for Q1 2016.